1. Resveratrol suppresses lung cancer by targeting cancer stem-like cells and regulating tumor microenvironment
    Chunfeng Xie et al, 2023, The Journal of Nutritional Biochemistry CrossRef
  2. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer
    Zhenbo Tu et al, 2017, International Journal of Oncology CrossRef
  3. Recent in vitro models and tissue engineering strategies to study glioblastoma
    Melike Karakaya et al, 2024, Biotech Studies CrossRef
  4. Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines
    Maximilian Hochmair et al, 2020, Investigational New Drugs CrossRef
  5. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066
    Cong-Cong Cheng et al, 2018, International Journal of Oncology CrossRef
  6. Integrated cancer tissue engineering models for precision medicine
    Michael E. Bregenzer et al, 2019, PLOS ONE CrossRef
  7. A potent indolylquinoline alleviates growth of human lung cancer cell tumorspheres
    Yu-Ling Ni et al, 2017, Apoptosis CrossRef
  8. Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
    Lia Walcher et al, 2020, Frontiers in Immunology CrossRef
  9. Tumor heterogeneity from the viewpoint of pathologists
    Eiichi Morii, 2023, Pathology International CrossRef
  10. Lung cancer stem cells markers and their potential therapeutic molecular targets
    Jagan Sundaram, 2024, Cancer Stem Cells and Signaling Pathways CrossRef
  11. Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer
    Kamal Shaik Fakiruddin et al, 2019, Cancers CrossRef
  12. 3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles
    Simonas Daunys et al, 2021, Bio-Nanomedicine for Cancer Therapy CrossRef
  13. Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
    Yue Zheng et al, 2022, Frontiers in Oncology CrossRef